Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
boston top stories
7
×
crispr
7
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
7
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
indiana blog main
indiana top stories
ipo
cancer
deals
eli lilly
fda
glaxosmithkline
medical devices
novartis
startups
biogen
gene editing
gene therapy
What
bio
roundup
crispr
life
moves
new
science
big
cas
companies
develop
mammoth
millions
remains
talk
therapeutics
week
allogene
approval
available
bails
based
becker
billions
biogen’s
biopharmaceutical
biosciences
black
bosley's
bosley’s
brand
bridge
bridgebio
bucks
cancer
capital
car
ceo
cheaper
continue
Language
unset
Current search:
crispr
×
biotech
×
" san francisco top stories "
×
" boston top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More